Nice-Systems Ltd (NICE.TA)

NICE.TA on Tel Aviv Stock Exchange

18,480.00
10:24am EST
Price Change (% chg)

80.00₪ (+0.43%)
Prev Close
18,400.00₪
Open
18,390.00₪
Day's High
18,490.00₪
Day's Low
18,330.00₪
Volume
204,309
Avg. Vol
99,837
52-wk High
18,490.00₪
52-wk Low
13,060.00₪

NICE.TA

Chart for NICE.TA

About

Nice Systems Ltd (NICE) is a provider of solutions that enable enterprises and security organizations to extract insight from interactions, transactions and surveillance. Its solutions enable companies and public organizations to capture, manage, analyze and impact unstructured interaction, as well as transactional data,... (more)

Overall

Beta: 0.90
Market Cap (Mil.): ₪11,123.53
Shares Outstanding (Mil.): 60.30
Dividend: 61.24
Yield (%): 1.33

Financials

  NICE.TA Industry Sector
P/E (TTM): 62.79 27.25 19.12
EPS (TTM): 2.94 -- --
ROI: 4.20 19.15 15.27
ROE: 4.38 21.20 15.91
Search Stocks

Israel's Nice Systems Q3 profit, revenue gain

JERUSALEM, Nov 5 - Israeli software provider Nice Systems reported higher quarterly profit that handily topped estimates, boosted by growth in its analytic applications.

05 Nov 2014

UK cost agency NICE rejects another Roche cancer drug

LONDON - Another new cancer drug from Roche, this time for treating leukaemia, has been rejected by Britain's healthcare cost-effectiveness agency NICE on the grounds that data about its value is uncertain.

02 Oct 2014

UK cost agency NICE rejects another Roche cancer drug

LONDON, Oct 3 - Another new cancer drug from Roche , this time for treating leukaemia, has been rejected by Britain's healthcare cost-effectiveness agency NICE on the grounds that data about its value is uncertain.

02 Oct 2014

GSK melanoma pill backed by UK cost watchdog with price cut

LONDON - Britain's healthcare cost agency NICE has recommended a third new drug for melanoma, this time from GlaxoSmithKline, after the drugmaker offered to supply it at a discount to the state-run National Health Service.

17 Sep 2014

GSK melanoma pill backed by UK cost watchdog with price cut

LONDON, Sept 18 - Britain's healthcare cost agency NICE has recommended a third new drug for melanoma, this time from GlaxoSmithKline, after the drugmaker offered to supply it at a discount to the state-run National Health Service.

17 Sep 2014

Israel's Nice Systems Q2 profit falls, revenue up

TEL AVIV, July 30 - Israeli software provider Nice Systems posted lower second-quarter net profit that missed analysts' estimates by two cents and maintained its full year outlook.

30 Jul 2014

BRIEF-Nokia buys 3D geolocation capabilities from Nice Systems

HELSINKI, July 3 - Nokia Oyj : * Says buys 3d geolocation capabilities from Nice Systems Ltd (Reporting by Helsinki Newsroom)

03 Jul 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: S&P Capital IQ – STARS Reports
$127.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks